Patents/Assignees

Oncternal Therapeutics, Inc.

2 patents in portfolio

US12161626utility2024
Uses of Indolinone Compounds
0 cites
US12128026utility2024
Selective Androgen Receptor Degrader (SARD) Ligands and Methods of Use Thereof
0 cites